MTNB - Matinas BioPharma spikes on pre-clinical data for oral chemotherapy
2023-11-07 08:01:01 ET
More on Matinas Biopharma
- Matinas BioPharma Holdings, Inc. (MTNB) Q2 2023 Earnings Call Transcript
- Matinas BioPharma stock soars 80% on antifungal drug update
- Seeking Alpha’s Quant Rating on Matinas Biopharma
- Historical earnings data for Matinas Biopharma
- Financial information for Matinas Biopharma
For further details see:
Matinas BioPharma spikes on pre-clinical data for oral chemotherapy